Inhibitors of Tumoral Necrosis Factor Alpha in Inflammatory Bowel Disease
The treatment of inflammatory bowel disease (IBD) has undergone a major paradigm shift in the last two decades with the introduction of biological drugs. Tumoral necrosis factor (TNF) antagonists were the first monoclonal antibodies available for treatment of IBD. New emerging concepts as early init...
Guardado en:
| Autores principales: | , , |
|---|---|
| Formato: | Capítulo de libro |
| Lenguaje: | inglés |
| Publicado: |
IntechOpen
2020
|
| Materias: | |
| Acceso en línea: | https://www.intechopen.com/chapters/70282 |
| Etiquetas: |
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares: Inhibitors of Tumoral Necrosis Factor Alpha in Inflammatory Bowel Disease
- Pathogenesis of Inflammatory Bowel Diseases
- Biosimilars in Inflammatory Bowel Diseases: General Concepts and Clinical Implications
- Surgical Interventions in Inflammatory Bowel Disease
- Gut Microbiota and Inflammatory Bowel Disease
- Insights to the Ethiopathogenesis of the Inflammatory Bowel Disease
- Gene Polymorphisms and Inflammatory Bowel Diseases